Sanofi's Matthew Ros Joins Epizyme
Epizyme Inc. has appointed Matthew Ros chief operating officer (COO). Ros joins the clinical-stage biopharma company from Sanofi, where he was most recently COO, global head of the oncology business unit, overseeing its solid tumour and hematology franchise. Prior to this, he worked within Genzyme’s rare disease business, where he led its second-largest franchise, Pompe disease, as vice president and franchise head. He has also previously served on the board of trustees at CancerCARE.